Randomized, Open-label Crossover Study to Evaluate Comparative Pharmacokinetics of Vitamin D3 Between DP-R206(150mg Ibandronate / 24,000 IU Vitamin D3 tablet) and a 24,000 IU Vitamin D3 in healthy adult volunteers

Trial Profile

Randomized, Open-label Crossover Study to Evaluate Comparative Pharmacokinetics of Vitamin D3 Between DP-R206(150mg Ibandronate / 24,000 IU Vitamin D3 tablet) and a 24,000 IU Vitamin D3 in healthy adult volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs Colecalciferol (Primary) ; Colecalciferol/ibandronic-acid (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacokinetics
  • Acronyms DP-R206
  • Sponsors Alvogen; DreamPharma Corporation
  • Most Recent Events

    • 31 Oct 2016 Status changed from recruiting to completed.
    • 14 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top